The use of cannabis to treat the symptoms of post-traumatic stress disorder (PTSD) is on the rise, but this increase isn’t yet supported by the evidence, suggests a new study from University College London (UCL)
“There has been a recent surge of interest in the use of cannabinoids to treat PTSD, particularly from military veterans, many of whom are already self-medicating or obtaining prescriptions in some American states,” said Chandni Hindocha, a researcher at UCL’s Clinical Psychopharmacology Unit and the study’s lead author.
The paper, published in the Journal of Dual Diagnosis concluded that cannabis may potentially help reduce the sleep disturbances that are a hallmark of PTSD, but that additional research is required before these drugs should be used in routine clinical prescription.
PTSD, a condition that affects up to one percent of the general population, involves the re-experiencing of traumatic events. This manifests as